Quick Takeaways
- GLAZER CAPITAL, LLC filed SCHEDULE 13G for IGM Biosciences, Inc. Common Stock, par value $0.01 per share (IGMS).
- Disclosed ownership: 7.3%.
- Date of event: 02 Jul 2025.
GLAZER CAPITAL, LLC - 02 Jul 2025 SCHEDULE 13G Report for IGM Biosciences, Inc. Common Stock, par value $0.01 per share (IGMS)
- Filing Manager
- GLAZER CAPITAL, LLC
- Reporting Manager
- Glazer Capital, LLC
- Symbol
- IGMS
- Shares outstanding
- 34,723,329 shares
- Disclosed Ownership
- 2,534,803 shares
- Ownership
- 7.3%
- Form type
- SCHEDULE 13G
- Filing time
- 09 Jul 2025, 17:21:47 UTC
- Date of event
- 02 Jul 2025
- Next filing
- 13 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GLAZER CAPITAL, LLC disclosed 7.3% ownership in IGM Biosciences, Inc. Common Stock, par value $0.01 per share (IGMS) on 02 Jul 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 09 Jul 2025, 17:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Glazer Capital, LLC | 7.3% | 2,534,803 | 0 | 2,534,803 | Paul J. Glazer | Paul J. Glazer, Managing Member | |
| Paul J. Glazer | 7.3% | 2,534,803 | 0 | 2,534,803 | Paul J. Glazer | Paul J. Glazer |